[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fbW_DU_TbZx-Sf6F-Vbf_i7r59kg14l4_He-21vyHL6w":8,"$fPRp2LRh2VmcIHGGZbO_oxzK9cTvu2UgNnS3DKNwsPHM":55,"$fRhQ2E3JG1efg3TAhOPwQZtFn1zCTRYpA4u2L6i0OsYE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},47999,867247,[],"https://ystcdn.venuertc.com/medical/ystApp/1xw1sX90VVZF00S00PejDww6VISBT3Dy.png","臧一兵","聊城市第二人民医院","胸外科","主治医师",543,0,"紫杉醇、顺铂与免疫药物联合用药详细指南","","https://ystcdn.venuertc.com/venue/AI/23fceafe-a51f-4773-bd30-ee13f5516bf6.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">紫杉醇、顺铂与免疫药物联合用药详细指南\u003C/h2>\n  \n  \u003Cdiv class=\"drug-guide-intro\">\n    联合化疗和免疫治疗在肿瘤治疗领域应用广泛，像紫杉醇、顺铂以及免疫检查点抑制剂这一组合，就是临床上常见的治疗方案。虽然药品本身大家可能不陌生，但使用过程中的各种细节和注意事项却容易被忽视。本文将带您系统梳理紫杉醇、顺铂及免疫药物合用时的8个关键用药细节，从剂型、服用方式到储存和不良反应，帮助患者更安心、更规范地使用这些药物。\n  \u003C/div>\n  \n  \u003C!-- 01 剂型与给药途径 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #fbfcff;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 💉 剂型和给药方式有什么讲究？\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cstrong>紫杉醇与顺铂：\u003C/strong>这两种药品都是\u003Cstrong>注射剂\u003C/strong>，不能口服，通常经静脉点滴给药。 \n      \u003Cul>\n        \u003Cli>紫杉醇为乳剂，稀释后静滴，一般至少3小时，过快可增副作用风险。\u003C/li>\n        \u003Cli>顺铂为透明溶液，同样需稀释静滴，输注时长也应超过1-2小时。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>免疫检查点抑制剂：\u003C/strong>如帕博利珠单抗（Keytruda）、纳武利尤单抗（Opdivo）等，均为注射用单抗药物，静脉滴注时间一般为30-60分钟。\n      \u003Cdiv class=\"drug-guide-tip\">正确做法：严格遵循医护人员操作，家庭不能自行操作药物输注。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 02 用药顺序与联合要点 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f7faf8;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 🗂️ 用药顺序和合用时要注意什么？\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      化疗药物常与免疫药物联合使用，但顺序有要求：\n      \u003Cul>\n        \u003Cli>紫杉醇、顺铂通常先注射，再用免疫抑制剂。\u003C/li>\n        \u003Cli>每一种药的溶液单独静脉输注，禁止合一瓶输入，避免药物反应。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">需要注意：合用化疗药和免疫药时，严格分开通路和输液管路，减少药物间不良反应。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 正确用量与个体化调整 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #fdf6f6;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 📏 用法用量和个体化调整的要点\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      药品剂量根据体表面积、肾功能、肝功能、年龄分层调整，常见剂量单位为“mg/m²”。\n      \u003Cul>\n        \u003Cli>紫杉醇：常用剂量为135-175mg/m²，一般每3周一次。\u003C/li>\n        \u003Cli>顺铂：剂量多为60-80mg/m²，每3-4周一次。\u003C/li>\n        \u003Cli>免疫药物：如帕博利珠单抗固定每3周一次200mg静脉滴注，纳武利尤单抗通常为每2周一次。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">正确做法：务必遵医嘱精准剂量，不能按患者自我感觉随意增减，超量风险极大。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 04 药理作用机制解析 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f6fafc;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 ⚙️ 药理机制如何发挥作用？\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cstrong>紫杉醇：\u003C/strong>通过稳定细胞内微管结构，阻止细胞分裂。\u003Cbr>\n      \u003Cstrong>顺铂：\u003C/strong>通过与DNA结合，导致链断裂和无法复制。\u003Cbr>\n      \u003Cstrong>免疫药物：\u003C/strong>如帕博利珠单抗、纳武利尤单抗，阻断肿瘤细胞逃避免疫攻击的“刹车”，激活机体自身免疫系统发挥作用。\n      \u003Cdiv class=\"drug-guide-tip\">这些机制协同增强整体治疗效果。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 05 常见不良反应要点 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f6f8fb;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 🩹 常见不良反应和应对办法\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cstrong>紫杉醇：\u003C/strong>脱发、乏力、白细胞减少和神经毒性较典型，部分病例可见过敏反应。\u003Cbr>\n      \u003Cstrong>顺铂：\u003C/strong>肾功能损害、听力下降、恶心、呕吐较为常见。\u003Cbr>\n      \u003Cstrong>免疫药物：\u003C/strong>可能诱发皮疹、甲状腺功能异常、免疫相关性肝炎等。\n      \u003Cul>\n        \u003Cli>联合应用时，需动态检测血象、电解质、肝肾功能。\u003C/li>\n        \u003Cli>遇有皮疹、发热性中性粒细胞减少等严重情况，必须及时停药就医。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">正确做法：如出现持续发热、皮疹、呼吸困难等异常，暂停用药立刻就诊。\u003C/div>\n      \u003Cdiv class=\"drug-guide-case\">\n        \u003Cspan class=\"drug-guide-case-icon\">📍\u003C/span>\n        有位70岁男性患者在接受该联合化疗序列时，出现轻度血象下降，经调整支持用药后症状改善。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 特殊人群用药和调整原则 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f6f7f6;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 👤 特殊人群与剂量调整\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>肾功能或肝功能减弱时，须适当降低剂量，密切监测不良反应发生率。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇与哺乳期女性：\u003C/strong>紫杉醇、顺铂明确禁用，免疫药物多数亦不推荐使用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能不全者：\u003C/strong>尤其使用顺铂和紫杉醇，更易出现毒性；需医生综合评估调整剂量。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">正确做法：特殊人群千万不可自行调整或停用药物，治疗过程中需频繁化验监测。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 药物相互作用详细说明 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #fcf8f6;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 ⚖️ 药物相互作用防控技巧\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cul>\n        \u003Cli>紫杉醇和顺铂联合时，通常先用紫杉醇，防止顺铂加重紫杉醇的毒性反应。\u003C/li>\n        \u003Cli>不要与强抑酸剂（如奥美拉唑）、某些抗真菌药（酮康唑）、抗生素（红霉素）、地尔硫卓等同用，以免影响代谢。\u003C/li>\n        \u003Cli>免疫药物合用糖皮质激素，会削弱免疫增敏效应。无需特殊情况，避免常规用激素。\u003C/li>\n        \u003Cli>辅助药（如抗呕吐药）可参与治疗，但需排除与化疗药物的冲突。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">建议做法：将所有在用药物主动告知医生和药师，切勿自行增减或调换药品。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 08 储存与运输的正确方法 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f6fbf7;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 📦 储存与药品运输要求\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cul>\n        \u003Cli>紫杉醇、顺铂和免疫药物均需密封避光，存储于2-8℃冰箱冷藏保存，不可冷冻。\u003C/li>\n        \u003Cli>开瓶后剩余药液需当日用完，不能隔日再用。\u003C/li>\n        \u003Cli>运输过程中必须有专业冷链设备，如遇室温暴露时间超过推荐限度，严禁使用。\u003C/li>\n        \u003Cli>过期或变色的药液，马上弃用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">推荐做法：药品购买和携带途中，一定索要冷链凭证，存于家庭专用医用冰箱最妥当。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 09 漏服与过量应对策略 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #fbfbf6;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 ⏰ 如果漏服或用量过大怎么办？\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      由于这些药品均为静脉点滴处方，必须在医院由专人操作。\u003Cbr>\n      \u003Cul>\n        \u003Cli>漏一次治疗：应与主管医生联系，评估下次给药时间，不得自行提前或重复补药。\u003C/li>\n        \u003Cli>过量给药风险：部分药物超量可短时间诱发严重毒性反应，如出现突发呕吐、抽搐、意识障碍等，需立即医院就诊。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">特别提醒：一旦怀疑操作失误，应立即求助医护人员，不可擅自调整治疗计划。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 10 支持用药和对症处理的正确姿势 -->\n  \u003Csection class=\"drug-guide-section\" style=\"background: #f6faF6;\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 💊 支持用药配合须知\u003C/h2>\n    \u003Cdiv class=\"drug-guide-content\">\n      \u003Cul>\n        \u003Cli>化疗期间常需联合止吐药（如昂丹司琼）、祛痰药与防过敏药物（如地塞米松），以减轻不适。\u003C/li>\n        \u003Cli>辅助药也应根据具体方案选用，切勿与主药并瓶混用。\u003C/li>\n        \u003Cli>所有配伍药品需由医师或药师审核后使用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"drug-guide-tip\">案例归纳：有患者在化疗期间配合正规止吐药使用，恶心反应得到良好控制。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 结语/重点提醒 -->\n  \u003Cdiv class=\"drug-guide-summary\" style=\"background: #fcf9fb;\">\n    \u003Ch2 class=\"drug-guide-sumtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">总结与用药提醒\u003C/h2>\n    \u003Cdiv>\n      紫杉醇、顺铂与免疫药物联合应用，疗效强，但用药过程每个环节都必须科学规范。不仅剂量需要严格控制，储存和输注环节也有不可忽视的安全风险。希望大家记住：\u003Cbr>\n      \u003Cstrong>一是任何环节都不能自行调整；二是药物储存、携带要确保全程冷链；三是辅助用药需经专科评估。\u003C/strong>\u003Cbr>\n      用好这些药品，有赖于患者、医师、药师密切合作。如有用药疑问，请及时咨询专业医生或药师。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003C!-- 文献引用 -->\n  \u003Cdiv class=\"drug-guide-reference\" style=\"background: #f7f8fb;\">\n    \u003Ch3 class=\"drug-guide-reftitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h3>\n    \u003Col>\n      \u003Cli>\n        Brahmer, J. R., Lacchetti, C., & Thompson, J. A. (2018). Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology, 36(17), 1714-1768. https://doi.org/10.1200/JCO.2017.77.6385\n      \u003C/li>\n      \u003Cli>\n        Markman, M., & Kennedy, A. (2017). Combination chemotherapy regimens in the treatment of patients with advanced cancer. Nature Reviews Clinical Oncology, 14(9), 529-540.\n      \u003C/li>\n      \u003Cli>\n        Liddle, C., & Goodin, S. (2016). Potential drug interactions with chemotherapy agents. American Journal of Health-System Pharmacy, 73(11), 699-712.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-container {\n  font-family: \"Segoe UI\", Arial, sans-serif;\n  line-height: 2;\n  color: #26313c;\n  background: #fff;\n  max-width: 830px;\n  margin: 32px auto;\n  border-radius: 14px;\n  box-shadow: 0 4px 16px 0 rgba(98,115,135,0.11),0 1.5px 5px 0 rgba(36,48,60,0.07);\n  padding: 38px 36px 40px 36px;\n  box-sizing: border-box;\n}\n.drug-guide-title {\n  font-size: 32px;\n  font-weight: 700;\n  margin-bottom: 18px;\n  color: #47506a;\n  letter-spacing: 1.2px;\n  text-align: center;\n}\n.drug-guide-intro {\n  font-size: 18px;\n  color: #617187;\n  margin-bottom: 32px;\n  padding: 18px 22px 15px 22px;\n  background: linear-gradient(90deg, #fde8cb 0%, #f6faff 90%);\n  border-radius: 9px;\n  border-left: 6px solid #f2af40;\n  box-sizing: border-box;\n}\n.drug-guide-section {\n  border-radius: 16px;\n  margin-bottom: 32px;\n  border: 1.5px solid #eeeff4;\n  padding: 32px 28px 22px 28px;\n  font-size: 18px;\n  box-sizing: border-box;\n  box-shadow: 0 1.5px 10px 0 rgba(80,110,165,0.06);\n}\n.drug-guide-subtitle {\n  font-size: 22px;\n  font-weight: 600;\n  letter-spacing: 1.3px;\n  margin-bottom: 17px;\n  color: #284e6c;\n  background: linear-gradient(90deg, #e7f3fa 0%, #fff 100%);\n  border-radius: 7px;\n  padding: 8px 0 8px 18px;\n  line-height: 1.2;\n  box-sizing: border-box;\n}\n.drug-guide-content {\n  font-size: 18px;\n  color: #2b3651;\n  padding-left: 6px;\n  padding-right: 2px;\n}\n.drug-guide-tip {\n  background: #f7fbe5;\n  color: #4e7c1d;\n  font-size: 16px;\n  border-radius: 7px;\n  margin: 15px 0 4px 0;\n  padding: 10px 15px 10px 14px;\n  letter-spacing: 0.8px;\n  border-left: 4.5px solid #8ad34a;\n  line-height: 1.6;\n}\n.drug-guide-case {\n  background: #fcf8e5;\n  color: #564204;\n  margin: 18px 0 0 0;\n  padding: 9px 11px;\n  border-radius: 8px;\n  border-left: 4px solid #ecc445;\n  font-size: 16px;\n  display: flex;\n  align-items: center;\n}\n.drug-guide-case-icon {\n  font-size: 18px;\n  margin-right: 7px;\n}\n.drug-guide-summary {\n  font-size: 19px;\n  color: #383952;\n  background: linear-gradient(90deg, #fff5ec 1%, #f7fafe 99%);\n  border-radius: 12px;\n  padding: 32px 22px 22px 24px;\n  margin: 42px 0 25px 0;\n  line-height: 2.1;\n  border-left: 4px solid #f2971b;\n}\n.drug-guide-sumtitle {\n  font-weight: 600;\n  color: #be6509;\n  font-size: 23px;\n  margin-bottom: 7px;\n  letter-spacing: 1.2px;\n}\n.drug-guide-reference {\n  margin-top: 42px;\n  font-size: 17px;\n  color: #394667;\n  background: #f8fbf9;\n  padding: 28px 22px 22px 24px;\n  border-radius: 10px;\n  border-left: 4px solid #4385a4;\n}\n.drug-guide-reftitle {\n  color: #285e88;\n  font-size: 20px;\n  font-weight: 600;\n  margin-bottom: 9px;\n}\n@media (max-width: 880px) {\n  .drug-guide-container {\n    max-width: 99vw;\n    padding: 22px 2vw 35px 2vw;\n  }\n  .drug-guide-title {\n    font-size: 25px;\n  }\n  .drug-guide-section {\n    padding: 22px 6vw 12px 6vw;\n    font-size: 15px;\n  }\n  .drug-guide-summary, .drug-guide-reference {\n    padding-left: 3vw;\n    padding-right: 7vw;\n    font-size: 16px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"drug-guide-title\" style=\"color: ",514,"2025-07-10 11:23:58","紫杉醇, 顺铂, 免疫药物, 联合化疗, 不良反应, 用药指南, 癌症治疗, 输注注意事项","了解紫杉醇、顺铂及免疫药物的联合应用细节，提升治疗效果并减少不良反应，确保用药安全。适合癌症患者、家属及医护人员阅读。","2025-07-12 00:40:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]